iShares Trust - iShares LifePath Target Date 2060 ETF EBIT

iShares Trust - iShares LifePath Target Date 2060 ETF (ITDH) currently reports a EBIT of $-1.9M as of March 2026. That compares with $20M in the prior-year period — down 109.5% year over year. That is above the sector sector average of $-69M. Use the charts on this page to explore iShares Trust - iShares LifePath Target Date 2060 ETF's EBIT history and peer comparisons.

iShares Trust - iShares LifePath Target Date 2060 ETF's EBIT decreased from $20M to $-1.9M — a 109.5% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

iShares Trust - iShares LifePath Target Date 2060 ETF's EBIT of $-1.9M is higher than the its sector sector average of $-69M. That is roughly 97.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

iShares Trust - iShares LifePath Target Date 2060 ETF reported $-1.9M in EBIT as of March 2026. That compares with $20M in the prior-year period — down 109.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-1.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-69M. From there, open related valuation or income-statement pages for iShares Trust - iShares LifePath Target Date 2060 ETF, and consider following ITDH for alerts when major investors trade the stock.